- Home
- NVGS vs OPK Comparison
NVGS vs OPK Comparison
Compare NVGS & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVGS | OPK |
|---|---|---|
| Founded | 1997 | 2007 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | NVGS | OPK |
|---|---|---|
| Price | $17.54 | $1.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $21.50 | $2.28 |
| AVG Volume (30 Days) | 317.9K | ★ 2.8M |
| Earning Date | 11-04-2025 | 10-29-2025 |
| Dividend Yield | ★ 1.60% | N/A |
| EPS Growth | ★ 33.99 | N/A |
| EPS | ★ 1.50 | N/A |
| Revenue | $578,158,000.00 | ★ $642,067,000.00 |
| Revenue This Year | $2.77 | N/A |
| Revenue Next Year | $0.18 | N/A |
| P/E Ratio | $11.67 | ★ N/A |
| Revenue Growth | ★ 2.46 | N/A |
| 52 Week Low | $10.55 | $1.11 |
| 52 Week High | $18.29 | $2.04 |
Technical Indicators
Market Signals| Indicator | NVGS | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 53.55 | 52.93 |
| Support Level | $17.20 | $1.28 |
| Resistance Level | $18.07 | $1.35 |
| Average True Range (ATR) | 0.35 | 0.05 |
| MACD | -0.12 | 0.01 |
| Stochastic Oscillator | 37.00 | 68.30 |
Price Performance
Historical ComparisonAbout NVGS Navigator Holdings Ltd. (Marshall Islands)
Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture). Company play a vital role in theglobalised liquefied gas supply chain, providing gas transportation solutions for energy companies, industrial users and commodity traders.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.